Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2022 | 09-2021 | 09-2020 | 09-2019 | 09-2018 | |
| Sales | 21,757 | 21,937 | 8,122 | 4,934 | 1,402 |
| Cost of Goods | 14,445 | 13,324 | 4,826 | 2,556 | 1,018 |
| Gross Profit | 7,312 | 8,613 | 3,296 | 2,378 | 384 |
| Operating Expenses | 30,822 | 14,539 | 9,548 | 13,075 | 1,056 |
| Operating Income | -23,065 | -5,601 | -5,426 | -10,141 | -654 |
| Interest Expense | 6,415 | 5,295 | 6,960 | 343 | 2 |
| Other Income | -1,686 | -9 | 0 | 535 | 34 |
| Pre-tax Income | -31,166 | -10,906 | -12,386 | -9,949 | -621 |
| Income Tax | 13 | N/A | -86 | N/A | 89 |
| Net Income Continuous | -31,179 | -10,906 | -12,300 | -9,949 | -710 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 21 |
| Minority Interests | -36 | N/A | -26 | -124 | N/A |
| Net Income | $-31,143 | $-10,906 | $-12,273 | $-9,825 | $-689 |
| EPS Basic Total Ops | -0.33 | -0.14 | -0.20 | -0.16 | -0.01 |
| EPS Basic Continuous Ops | -0.33 | -0.14 | -0.20 | -0.16 | -0.01 |
| EPS Diluted Total Ops | -0.33 | -0.14 | -0.20 | -0.16 | -0.01 |
| EPS Diluted Continuous Ops | -0.33 | -0.14 | -0.20 | -0.16 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.14 | N/A | N/A | N/A |
| EBITDA(a) | $-17,335 | $-449 | $356 | $-9,465 | $-604 |